Ipilimumab vs Trimethoprim
Ipilimumab vs Trimethoprim: Overview
This comparison examines the pharmacological differences between Ipilimumab and Trimethoprim.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Trimethoprim: Dihydrofolate reductase inhibitor (bacterial selective).
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Trimethoprim — 8-10 hours.
Chemical Properties
Molecular Formula: Trimethoprim — C14H18N4O3.
Molecular Weight: Trimethoprim — 290.3180 g/mol.
Type: Ipilimumab — Antibody; Trimethoprim — Small molecule.